0.18
-0.005(-2.78%)
Currency In CAD
Address
339–50th Avenue SE
Calgary, AB T2G 2B3
Canada
Phone
587 779 6166
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
N/A
First IPO Date
July 24, 2013
| Name | Title | Pay | Year Born |
| Brent Willis | President, Chief Executive Officer & Director | 132,000 | 1971 |
| Iryna Saranchova | Chief Scientific Officer | 2,160 | N/A |
| Ibrahim Hashmi | Vice President of Business Development | 13,200 | N/A |
| Albert Deslauriers | Chief Financial Officer | 102,800 | N/A |
| Bradley Craig Willis | Founder, Chief Operating Officer & Director | 126,000 | 1971 |
| Ethan Mohan | Executive Vice President | 0 | N/A |
Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.